To decide whether adenosine 3':5'-cyclic monophosphate (cyclic AMP) plays a role as a second messenger in the trans-synaptic induction of tyrosine 3-monooxygenase (EC 1.14.16.2), it is desirable to discriminate between neuronal and extraneuronal changes in cyclic AMP concentration. Treatment of newborn rats with nerve growth factor antiserum or 6-hydroxydopamine, leading to destruction of 61485% of the adrenergic nerve cell bodies in the superior cervical ganglion, led to a decrease in cyclic AMP of only 16-28%. This observation demonstrates that a relatively Amall portion of cyclic AMP is localized in the adrenergic neurons. However, administration of isoproterenol produced an increase (12-fold) in cyclic AMP only in this neuronal pool. Neither single nor repeated injections of isoproterenol led to induction of tyrosine monooxygenase. This, together with previous observations that experimental conditions leading to induction of the enzyme do not produce significant increases of cyclic AMP in the whole ganglion, is taken as an indication that cyclic AMP is not acting as a second messenger in the trans-synaptic induction of tyrosine monooxygenase in the rat superior cervical ganglion. In the rat adrenal medulla, treatment with reserpine led to both a shortlasting (60-90 min) increase in cyclic AMP and a subsequent induction of tyrosine monooxygenase. However, the increase in cyclic AMP was almost completely prevented (40 compared to 320%) by pretreatment of the rats with propranolol while the induction of tyrosine monooxygenase was not diminished. This observation also argues against an exclusive key-function of cyclic AMP in trans-synaptic induction of tyrosine monooxygenase in the adrenal medulla.
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In the peripheral sympathetic nervous system an increased activity of the preganglionic cholinergic fibers leads to an increased synthesis of tyrosine 3-monooxygenase (EC 1.14.16.2) and dopamine j3-monooxygenase (EC 1.14.17.1) in the adrenergic neurons and adrenal chromaffin cells (for further references, see refs. 1 and 2). In sympathetic ganglia this induction can be abolished by transecting the preganglionic cholinergic fibers (3, 4) or by administration of nicotinic blocking agents (5) . Moreover, high doses of acetylcholine or carbachol have been reported to lead to an increase in tyrosine monooxygenase activity in denervated adrenals (6, 7) . These findings suggest that acetylcholine acts as the first messenger in transsynaptic induction of tyrosine monooxygenase and dopamine P-monooxygenase.
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The fact that stimulation of preganglionic cholinergic fibers produces a marked increase in adenosine 3': 5'-cyclic monophosphate (cAMP) in the rabbit superior cervical ganglion (8, 9) and that high concentrations (1-5 mM) of dibutyryl cAMP produce a cycloheximide-sensitive increase in tyrosine monooxygenase in mouse superior cervical ganglia in organ culture (10) could be taken as an indication that this nucleotide acts as a second messenger in trans-synaptic enzyme induction. Moreover, Costa and collaborators (7, 11, 12) reported on experimental conditions in which a correlation between the rate of increase in cAMP and subsequent tyrosine monooxygenase induction in the rat adrenal medulla became apparent.
However, the rise in cAMP in rabbit superior cervical ganglion after preganglionic stimulation appears to be mediated by a sequential muscarinic-dopaminergic mechanism (8, 9) whereas trans-synaptic induction is mediated by a nicotinic mechanism (5) . Moreover, concentrations of dibutyryl cAMP leading to increases in enzyme activities in sympathetic ganglia in organ culture do not discriminate between those enzymes specifically increased by trans-synaptic induction in vivo, tyrosine monooxygenase and dopamine P-monooxygenase, and enzymes not increased under these conditions (28 Assay of Cyclic AMP. After appropriate time intervals following the last treatment, which are indicated in Table 1 and figures, the animals were killed by a blow on the head and cervical ganglia and/or adrenal glands were rapidly removed. In contrast to the central nervous system, the speed of removal of these organs is not so critical with respect to the amount of cAMP subsequently determined (13) . Two ganglia or two adrenal medullae (contamination with cortex tissue <5% as verified histologically) were homogenized in 300 of 5% trichloroacetic acid. After centrifugation at 5000 X g for 15 min, the supernatant fractions were extracted three times with 7 ml of diethylether, and cAMP concentrations were determined in 50-;, aliquots of the aqueous fractions according to Fisch et al. (14) . The protein of the trichloroacetic acid precipitate was dissolved in 1 N NaOH and determined by the method of Lowry et al. (15) .
Assay of Tyrosine Monooxygenase. The animals were killed 48 hr after the last treatment, except where stated otherwise (see Table 1 and Fig. 2 ). One pair of adrenals was homogenized in 4 ml, one pair of superior cervical ganglia in 0.5 ml of 5 mM Tris HCl (pH 7.4) containing 0.1% (w/v) Triton X-100. The homogenates were centrifuged at 10,000 X g for 20 min, and the supernatant fractions were used for determination of tyrosine monooxygenase activity by the method of Levitt et al. (16) (Fig. 1A) . A second dose of isoproterenol within 60 min after the first treatment led to much smaller increases in cAMP (data not shown), possibly reflecting refractoriness of an isoproterenol-sensitive receptor, depletion of the substrate for adenylate cyclase, ATP, or an enhanced degradation of cAMP (20) (21) (22) . However, multiple doses of isoproterenol given 90 min apart from each other consistently produced maximal increases after every dose (Fig. 1B) Levels of cAMP were determined at the time intervals indicated; in vitro activity of tyrosine monooxygenase was determined 48 hr after the first dose of isoproterenol. Values represent means 1 SEM of at least six determinations. *, P < 0.05; **, P < 0.001. no induction of tyrosine monooxygenase could be observed. Tyrosine monooxygenase activity was determined 48 hr after the first dose of isoproterenol. Previous studies had shown that tyrosine monooxygenase levels are elevated from 24 to 72 hr after stimulus (and usually even considerably longer) with peak activities around 48 hr (17, 25) .
Effect of Reserpine and/or Propranolol on Levels of cAMP and Activity of Tyrosine Monooxygenase in Adrenal Medulla. Reserpine produced a very marked increase in adrenal medullary cAMP, which amounted to 410% of controls 30 min after injection. This increase in cAMP was almost completely prevented by pretreatment with D,-propranolol, whereas the trans-synaptic induction of tyrosine monooxygenase was not impaired (Fig. 3) . Propranolol alone did not produce any significant change in cAMP or tyrosine monooxygenase.
DISCUSSION
Treatment of newborn rats with several doses of 6-hydroxydopamine, producing a specific, extensive destruction of adrenergic neurons (for further references see ref. 26 ), led to a decrease in the levels of cAMP in the superior cervical ganglion of the rat by only 22% while the activity of tyrosine monooxygenase, an enzyme specifically located in adrenergic neurons (for further references see ref. 24) , was reduced to 15% of controls. This observation demonstrates that the major portion of cAMP is not located in the adrenergic nerve cell bodies of this ganglion. However, this treatment virtually abolished the increase in cAMP evoked by isoproterenol, indicating that only the relatively small cAMP pool located in the adrenergic nerve cell bodies is responsive to this drug. This interpretation is further supported by the following observations. Treatment with 6-hydroxydopamine at different dosage schedules led to reductions in isoproterenol-induced increases in cAMP which-within the limits of experimental error-corresponded to the reduction in the adrenergic marker enzyme, tyrosine monooxygenase (Fig. 2) . Moreover, destruction of the adrenergic neurons by a different mechanism, immunosympathectomy using NGF antiserum (for further references see ref. 27 ), again led to a reduction of the isoproterenol-evoked increase in cAMP corresponding to the decrease in tyrosine monooxygenase (Table 1) . This reduction of isoproterenol-induced increases in cAMP, evoked by two completely different means of destruction of adrenergic neurons and, moreover, corresponding to the decrease of the adrenergic marker enzyme tyrosine monooxygenase, strongly argues for the location of the isoproterenol-responsive cAMP pool in the adrenergic neurons. The observed increase in cAMP evoked by isoproterenol, which is 3-fold with respect to the total ganglion, appears to be 12-fold with respect to the relatively small cAMP pool located in the adrenergic nerve cell bodies.
Cramer and colleagues (19) observed that the stimulatory effect of isoproterenol on cAMP decreased in cultured rat superior cervical ganglia to less than 20% after 2 days while 40-60% of the ganglion cells appeared to survive. Since responses of ganglia kept in culture differ from those in vivo in several respects (28) , one of the reasons probably being that the axon has to be cut before the ganglion can be put in organ culture, the responsiveness of the apparently surviving cells may have been diminished.
The isoproterenol-induced increase in cAMP in the adrenergic neurons was not accompanied by a subsequent rise in tyrosine monooxygenase activity. Therefore, an attempt was made to keep cAMP levels elevated for a longer time period, since control levels were reached again as early as 15 min after administration of an optimal dose of isoproterenol. However, even after several maximal elevations of cAMP by repeated injections of isoproterenol, no trans-synaptic induction of tyrosine monooxygenase could be observed (Fig. 1B) . If cAMP should be involved in trans-synaptic induction of tyrosine monooxygenase in the superior cervical ganglion of the rat, one would have to assume not only several independent cAMP pools within the ganglion (neuronal and nonneuronal cells) but also within the adrenergic nerve cell body. The compartment of cAMP functionally linked to the process of trans-synaptic induction of tyrosine monooxygenase would have to be distinct from that which responds to isoproterenol. However, recent findings that experimental conditions that led to a trans-synaptic induction of tyrosine monooxygenase in sympathetic ganglia (swimming stress, treatment with reserpine) did not significantly change cAMP levels (13, 29), do not support such an assumption. If an elevation of cAMP in a specific intraneuronal pool, small when compared to the total intraneuronal cAMP, were essential for trans-synaptic induction of tyrosine monooxygenase, one would have to assume that this increase was so much overshadowed by the major cAMP pool(s) as not to be experimentally verifiable.
A dissociation between the changes in cAMP and the induction of tyrosine monooxygenase was also observed in the adrenals. In order to eliminate as much as possible interference from cAMP pools not located in the adrenal chromaffin cells in which tyrosine monooxygenase induction occurs, the adrenal cortex was removed before determination of the cAMP content. Reserpine, which leads to an induction of adrenal tyrosine monooxygenase, also led to a very marked increase in cAMP in the adrenal medulla. However, this increase was almost completely prevented by propranolol while this drug did not diminish the reserpine-induced increase in adrenal tyrosine monooxygenase (Fig. 3) . The data in Fig. 3 represent an "average" (i.e., typical) experiment. In some experiments the increase in cAMP was completely blocked by propranolol. Whereas prior division of the splanchnic nerve prevents both the elevation of cAMP and tyrosine monooxygenase activity produced by reserpine, cutting the nerve several hours after the cAMP response is completed but before the in vitro tyrosine monooxygenase activity has begun to change still prevents tyrosine monooxygenase induction (Mueller et al., in preparation) . Moreover, preliminary experiments have shown that a combination of reserpine and theophylline led in denervated adrenals to no change in tyrosine monooxygenase, yet within 30 min to an increase in cAMP (552 i 39% of controls) even greater than did reserpine in intact animals (Otten et al., in preparation). These observa-tions are again at variance with the thesis that increases in cAMP are linked to tyrosine monooxygenase induction. Both may, under certain conditions, be produced by the same stimulus, but reflect different cellular responses not causally related to each other.
Costa and Guidotti (11) suggested that in the adrenal medulla the rate of increase in cAMP may be functionally linked to tyrosine monooxygenase induction rather than maximal or total increases in this nucleotide and that induction of tyrosine monooxygenase occurs when the accumulation of cAMP proceeds at a rate of at least 10 pmol/mg of protein per min. In the present experiments a rate of accumulation of 40 pmol of cAMP/mg of protein per min did not lead to tyrosine monooxygenase induction in the superior cervical ganglion (Fig. 1) . This number is, of course, not directly comparable to the situation in adrenal medulla. However, the increase is confined to adrenergic neurons and the rate would, therefore, even be higher if expressed per mg of protein of the adrenergic nerve cell bodies. On the other hand, in the adrenal medulla induction of tyrosine monooxygenase was observed (Fig. 3 , reserpine + propranolol) under conditions that led to an initial increase in cAMP at a rate of 0.5 pmol/mg of protein per min only.
It is concluded that the dissociation between changes in cAMP located in the adrenergic nerve cell bodies of the superior cervical ganglion and in adrenal medulla and subsequent induction of tyrosine monooxygenase makes it unlikely that this nucleotide is crucially involved in linking the changes in the neuronal membrane effected by increased activity of the preganglionic neuron with the increase in the synthesis of a specific protein, tyrosine monooxygenase.
